Integrin targeted oncolytic adenoviruses Ad5‐D24‐RGD and Ad5‐RGD‐D24‐GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors

Dendritic cells and the control of immunity

1998 • 14,345 citations

Regulatory T cells, tumour immunity and immunotherapy

2006 • 2,009 citations

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

2003 • 1,418 citations

Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide

2005 • 878 citations

An Adenovirus Vector with Genetically Modified Fibers Demonstrates Expanded Tropism via Utilization of a Coxsackievirus and Adenovirus Receptor-Independent Cell Entry Mechanism

1998 • 764 citations

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo

2000 • 742 citations

Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma

2009 • 584 citations

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

2000 • 572 citations

A Phase I Study of OncoVEXGM-CSF, a Second-Generation Oncolytic Herpes Simplex Virus Expressing Granulocyte Macrophage Colony-Stimulating Factor

2006 • 541 citations

Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial

2008 • 499 citations

A randomized placebo-controlled phase III study of granulocyte- macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490)

1995 • 462 citations

Regulation of myeloid development and function by colony stimulating factors

2003 • 385 citations

Treatment of Cancer Patients With a Serotype 5/3 Chimeric Oncolytic Adenovirus Expressing GMCSF

2010 • 225 citations

Use of recombinant granulocyte-macrophage colony-stimulating factor during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia (AML): final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the research and treatment of cancer (EORTC-LCG) and the Dutch Belgian Hemato-Oncology Cooperative Group (HOVON)

1997 • 217 citations

Oncolytic Adenovirus Coding for Granulocyte Macrophage Colony-Stimulating Factor Induces Antitumoral Immunity in Cancer Patients

2010 • 213 citations

Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers.

1993 • 198 citations

Phase I–II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas

2005 • 168 citations

Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas.

1991 • 160 citations

Treatment of ovarian cancer with a tropism modified oncolytic adenovirus.

2002 • 156 citations

Cyclophosphamide Augments Antitumor Immunity: Studies in an Autochthonous Prostate Cancer Model

2009 • 153 citations

Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study

2010 • 131 citations

Low-dose Cyclophosphamide Treatment Impairs Regulatory T Cells and Unmasks AFP-specific CD4+ T-cell Responses in Patients With Advanced HCC

2010 • 122 citations

Current Developments In Adenovirus-Based Cancer Gene Therapy

2006 • 115 citations

Comparison of One-, Two-, and Three-Dimensional Measurements of Childhood Brain Tumors

2001 • 110 citations

Frequency, demographics and risk (according to tumour type or site) of cancer-associated thrombosis among patients seen at outpatient DVT clinics

2009 • 92 citations

A phase I trial of intravenous infusion of ONYX-015 and enbrel in solid tumor patients

2007 • 84 citations

Enhanced oncolysis by a tropism-modified telomerase-specific replication-selective adenoviral agent OBP-405 (‘Telomelysin-RGD’)

2005 • 84 citations

A phase I study of KH901, a conditionally replicating granulocyte-macrophage colony-stimulating factor: Armed oncolytic adenovirus for the treatment of head and neck cancers

2009 • 83 citations

Prolonged systemic circulation of chimeric oncolytic adenovirus Ad5/3-Cox2L-D24 in patients with metastatic and refractory solid tumors

2010 • 70 citations

Adenovirus hexon T-cell epitope is recognized by most adults and is restricted by HLA DP4, the most common class II allele

2004 • 64 citations

Intralesional Cytokine Therapy in Cancer

1998 • 55 citations

In situ adenovirus vaccination engages T effector cells against cancer

2009 • 53 citations

A cyclooxygenase-2 promoter-based conditionally replicating adenovirus with enhanced infectivity for treatment of ovarian adenocarcinoma

2004 • 50 citations

Activation of Tumor-Specific CD8+ T Cells after Intratumoral Ad5-TRAIL/CpG Oligodeoxynucleotide Combination Therapy

2007 • 47 citations

Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer

2004 • 43 citations

A modified E2F-1 promoter improves the efficacy to toxicity ratio of oncolytic adenoviruses

2009 • 43 citations

Systemic efficacy of oncolytic adenoviruses in imagable orthotopic models of hormone refractory metastatic breast cancer

2007 • 43 citations

Regulatory T cell depletion enhances tumor specific CD8 T-cell responses, elicited by tumor antigen NY-ESO-1b in hepatocellular carcinoma patients, in vitro

2010 • 42 citations

Identifying the safety profile of a novel infectivity-enhanced conditionally replicative adenovirus, Ad5-Δ24-RGD, in anticipation of a phase I trial for recurrent ovarian cancer

2007 • 40 citations

Intralesional granulocyte‐monocyte colony‐stimulating factor followed by subcutaneous interleukin‐2 in metastatic melanoma: a pilot study in elderly patients

2001 • 40 citations

Noninvasive imaging for evaluation of the systemic delivery of capsid‐modified adenoviruses in an orthotopic model of advanced lung cancer

2006 • 39 citations

Survivin promoter-based conditionally replicative adenoviruses target cholangiocarcinoma

2006 • 38 citations

Oncolytic adenovirus treatment of a patient with refractory neuroblastoma

2010 • 35 citations

Stimulation of suppressor cells in the bone marrow and spleens of high dose cyclophosphamide-treated C57Bl/6 mice

1987 • 29 citations

Live viruses in cancer treatment.

2002 • 27 citations

E1A, E1B Double-Restricted Adenovirus with RGD-Fiber Modification Exhibits Enhanced Oncolysis for CAR–Deficient Biliary Cancers

2007 • 24 citations

Linked Tumor-Selective Virus Replication and Transgene Expression from E3-Containing Oncolytic Adenoviruses

2005 • 19 citations